This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
JD Sports Fashion PLC | 144.4 | 8.6% |
Next PLC | 7,340.0 | 3.3% |
Convatec Group PLC | 222.0 | 2.7% |
Frasers Group PLC | 813.5 | 2.1% |
Marks And Spencer Group PLC | 235.3 | 1.8% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
Ocado Group PLC | 659.2 | -18.5% |
Flutter Entertainment PLC | 14,125.0 | -3.4% |
Antofagasta PLC | 1,410.5 | -3.1% |
Glencore PLC | 449.8 | -3.1% |
Croda International PLC | 4,902.0 | -3.1% |
Major World Indices | Price | % Chg | 1 YEAR |
UK 100 INDEX | 7,687 | -0.6% | 6.3% |
DOW JONES INDUS. AVG | 34,232 | -0.6% | 13.4% |
DAX INDEX | 15,584 | -1.3% | 21.8% |
NIKKEI 225 | 32,571 | -1.4% | 20.0% |
S&P/ASX 200 INDEX | 7,065 | -1.4% | 5.5% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 90.18 | 0.58% |
Brent Crude (ICE) | USD/bbl. | 93.88 | 0.37% |
Gold Spot | USD/t oz. | 1,920 | -0.5% |
Copper (Comex) | USd/lb. | 368 | -2.4% |
The UK 100 called to open -3 points at 7,675. The UK 100 looks set top open broadly flat after yesterdays surprise half from the MPC of the Bank of England. Data this morning saw retail sales rebounded in August after the bad weather kept consumers away from the high street in July. US stocks delivered heavy losses on Thursday after the Federal Reserve signalled interest rates would stay higher, for longer, after it held interest rates steady, a ‘hawkish’ hold, while the Bank of England’s pause in rates was perceived to be more ‘dovish’. In Japan, the Bank of Japan left its ultra-loose monetary policy in place, as was widely expected, and showed no sign of shifting its approach to monetary policy.
Ascential plc the specialist information, analytics, events and eCommerce optimisation company, today announces results for the six-month period to 30 June 2023. Delivering Strong organic revenue growth in all segments, led by Events (up 25%), Organic revenue growth of 16% with Adjusted EBITDA growing 17% – in line with expectations, they also said Strategic actions to maximise shareholder value and position each business within the portfolio for long-term success are well advanced. Market update expected before the end of the year.
ASTRAZENECA PLC said Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
Croda International Plc today announced that it has appointed Danuta Gray as a Non-Executive Director and Chair Designate. Danuta will join the Board with effect from 1 February 2024 and will succeed Dame Anita Frew (DBE) as Chair at the conclusion of the Company’s AGM on 24 April 2024
UK
None
US
None
UK
None
US
None
BoJ Interest Rate Decision
UK Retail Sales
BoJ Press Conference
German HCOB Composite PMI
German HCOB Manufacturing PMI
German HCOB Services PMI
EU HCOB Composite PMI
EU HCOB Manufacturing PMI
EU HCOB Services PMI
UK S&P Global/CIPS Composite PMI
UK S&P Global/CIPS Manufacturing PMI
UK S&P Global/CIPS Services PMI
US S&P Global Composite PMI
US S&P Global Manufacturing PMI
US S&P Global Services PMI
UK 100 companies going ex-dividend on 28th September 2023:
Barratt Developments
Phoenix Group Holdings
M&G
British American Tobacco
Smurfit Kappa Group
Rightmove
UK 250 companies going ex-dividend on 28th September 2023:
Foresight Group Holdings
TP ICAP Group
Petershill Partners
Hipgnosis Songs Fund
Kainos Group
Computacenter
Mercantile Investment Trust
HgCapital Trust
Games Workshop Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.